CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in GliomasLiling Liu, Jing Zeng, Hao Duan et al.|Frontiers in Oncology|2021Cited by 34
SSTR2 is a prognostic factor and a promising therapeutic target in glioma.Jiahua He, Jing Zeng, Qunxi Chen et al.|PubMed|2021Cited by 18
Single-cell and spatial transcriptomics reveal mechanisms of radioresistance and immune escape in recurrent nasopharyngeal carcinomaMing‐Yuan Chen, Tao Yu, Tianliang Xia et al.|Nature Genetics|2025Cited by 17